Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Vibeke, Backer"'
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports.
Autor:
Søren Jessen, Thomas Baasch‐Skytte, Johan Onslev, Kasper Eibye, Vibeke Backer, Jens Bangsbo, Morten Hostrup
Publikováno v:
Jessen, S, Baasch-Skytte, T, Onslev, J, Eibye, K, Backer, V, Bangsbo, J & Hostrup, M 2022, ' Muscle hypertrophic effect of inhaled beta 2-agonist is associated with augmented insulin-stimulated whole-body glucose disposal in young men ', Journal of Physiology, vol. 600, no. 10, pp. 2345-2357 . https://doi.org/10.1113/JP282421
Rodent studies highlight enhancement of glucose tolerance and insulin sensitivity as potential clinically relevant effects of chronic beta2-agonist treatment. However, the doses administered to rodents are incomparable with the therapeutic doses used
Autor:
Vibeke Backer, Laurits Frøssing, Marcus Ross Christensen, Katherine J. Baines, Alexander Silberbrandt, Ditte Kjærsgaard Klein, Anna Von Bülow, Celeste Porsbjerg
Publikováno v:
Clinical & Experimental Allergy. 52:59-69
BACKGROUND Type 2 inflammation is characterized by enhanced activity of interleukin (IL)-4, -5 and -13, and treatments targeting these pathways are available for treatment of severe asthma. At present, the pattern of pathway activity and the implicat
Autor:
Victoria Becker, Sebastian Rzeppa, Ingunn Hullstein, Vibeke Backer, Yvette Dehnes, Morten Hostrup, Kasper Høtoft Bengtsen, Søren Jessen
Publikováno v:
Drug Testing and Analysis. 13:747-761
As of 2020, use of beta2 -agonist salmeterol is restricted by the World Anti-Doping Agency (WADA) and is only permitted by inhalation at therapeutic doses not exceeding 200 μg in 24 h. In contrast to beta2 -agonists salbutamol and formoterol, WADA h
Autor:
Vibeke Backer, Jens Bangsbo, Sajad Habib, Anders Krogh Lemminger, Søren Jessen, Stella Feng Sheng Xu, Johan Onslev, Morten Hostrup
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 29:1881-1891
While beta2 -adrenoceptor stimulation has been shown to increase lean mass and to alter metabolic properties of skeletal muscle, adaptations in muscle oxidative enzymes and maximal oxygen uptake ( V˙ O2max ) in response to beta2 -adrenergic agonist
Publikováno v:
Allergy. 76:2318-2319
Autor:
Martin Thomassen, Michael Kreiberg, Lars Holm, Morten Hostrup, Vibeke Backer, Søren Jessen, Henriette Pilegaard, Jens Bangsbo, Michael Nyberg, Anders Kalsen, Caroline Maag Kristensen, Glenn A. Jacobson, Søren Reitelseder, Jon Egelund
Publikováno v:
The Journal of Physiology. 596:4121-4139
KEY POINTS Animal models have shown that beta2 -adrenoceptor stimulation increases protein synthesis and attenuates breakdown processes in skeletal muscle. Thus, the beta2 -adrenoceptor is a potential target in the treatment of disuse-, disease- and
Autor:
Jens Bangsbo, Morten Hostrup, Anders Krogh Lemminger, Johan Onslev, Vibeke Backer, Søren Jessen
Publikováno v:
Scandinavian Journal of Medicine & Science in Sports. 28:2114-2122
Due to a high prevalence of asthma and exercise-induced bronchoconstriction in elite athletes, there is a high use of beta2 -adrenoceptor agonists (beta2 -agonists) in the athletic population. While anabolic in rodents, no study has been able to dete
Autor:
Ingrid A. Laing, Vibeke Backer, Siew-Kim Khoo, Asger Bjerregaard, P. N. Le Souëf, Chisha Sikazwe, Asger Sverrild, Celeste Porsbjerg, David W. Smith, Glenys Chidlow
Publikováno v:
Clinical and Experimental Allergy
SummaryBackground The major trigger of asthma exacerbations is infection with a respiratory virus, most commonly rhinovirus. Type 2 inflammation is known to be associated with an increased risk of exacerbations in general. Whether type 2 inflammation
Autor:
Pal B. Szecsi, Kirsten Ohm Kyvik, Camilla Elmose, Vibeke Backer, Simon Francis Thomsen, Jacob P. Thyssen, Steen Stender
Publikováno v:
Thomsen, S F, Elmose, C, Szecsi, P B, Stender, S, Kyvik, K O, Backer, V & Thyssen, J P 2016, ' Filaggrin gene loss-of-function mutations explain discordance of atopic dermatitis within dizygotic twin pairs ', International Journal of Dermatology, vol. 55, no. 12, pp. 1341-1344 . https://doi.org/10.1111/ijd.13401
Objectives This study was designed to examine the association between loss-of-function mutations in the filaggrin gene (FLG) and atopic dermatitis (AD) and asthma in adult twins. Methods A previously well-characterized cohort of 575 adult twins were